ITERUM THERAPEUTICS PLC (ITRM) Stock Income Statement
NASDAQ:ITRM - Nasdaq - IE000TTOOBX0 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 15.65M | 47.47M | 30.38M | 24.54M | 32.12M | |||
| Research and Development | 7.07M | 39.99M | 17.62M | 10.71M | 21.07M | |||
| Selling, General, and Administrative Expenses | 8.57M | 7.48M | 12.77M | 13.83M | 11.05M | |||
| Operating Income | -16.24M | -47.47M | -30.38M | -24.54M | -32.12M | |||
| Interest Income/Expense | -6.00M | 9.63M | 3.10M | -66.52M | -16.84M | |||
| Other Income/Expense | -68.00K | 82.00K | 500.00K | 200.00K | 210.00K | |||
| Non Recurring Items | N/A | 0.00 | -17.35M | 0.00 | -2.51M | |||
| Income Before Taxes | -22.31M | -37.76M | -44.13M | -90.86M | -51.26M | |||
| Income Tax | 252.00K | 613.00K | 300.00K | 710.00K | 740.00K | |||
| Net Income | -22.56M | -38.37M | -44.43M | -91.56M | -52.01M | |||
| EBITDA | -15.62M | -45.72M | -28.58M | -22.44M | -31.96M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.00 | -2.96 | -3.63 | -8.41 | -32.49 | |||
| Non GAAP EPS | -0.97 | N/A | -2.28 | -11.55 | -38.55 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD